Why are Medicare and Medicaid shown separately instead of combined?

They come from two different CMS data sources with no shared claim identifier, so they can't be reconciled into one number without double-counting or guessing. Every table and chart on this page keeps them fully separate.

Why is there no private/commercial revenue figure?

Private and commercial payer data comes from Transparency in Coverage files, which only publish negotiated rates — not claims or utilization volume. Without a volume figure, no revenue number can be computed for any provider from that data.

What does "Rank" mean in the Competitive Analysis & Benchmarks tables?

For a given CPT/HCPCS code, it's this provider's position by claims volume among all providers billing that same code at that geography level (State, National, or Virginia for Medicaid) — rank 1 means the highest claims volume for that code.

Why is the Medicaid comparison limited to Virginia only?

Medicaid is administered per-state with no single national fee schedule, so a state or national comparison the way Medicare has one isn't available. Virginia (this provider's own state) is the only grouping that's conceptually meaningful.

Why are the numbers rounded to the nearest 10?

To avoid implying more precision than the underlying data supports at a single-provider level. Ratios are kept precise since they're a relative comparison, not a volume or dollar figure.

How current is this data?

The Medicare and Medicaid tables are both single current snapshots, not refreshed on a recurring schedule yet.

Reshma Katira (NPI 1700851607)

Field	Value
Entity Type	Individual
Organization	Reshma Katira
Address	6354 Walker Ln
City	Alexandria
State	VA
ZIP	22310
Taxonomy	Retina Specialist (Ophthalmology) Physician
NPI Enumerated	February 22, 2006

Payer Source	Total Paid
Medicare	$2.8M
Medicaid	$0

Key Findings

RESHMA KATIRA is operating as a retina-focused ophthalmology practice that is heavily weighted toward intravitreal biologic therapy: the three leading Medicare revenue drivers are anti-VEGF injection codes J0178, J2778 and J2777, and these procedure- and drug-based codes dominate the clinical mix. Code descriptions show routine in-office injections of agents such as aflibercept (J0178) and ranibizumab (J2778), consistent with a clinic organized around recurring retinal injections and follow-up ophthalmic care rather than primarily surgical retinal procedures.

Revenue concentration is pronounced: the top 3 Medicare codes by revenue account for 72.4% of this provider's total Medicare revenue. Specifically, J0178 accounts for $970.2K revenue (34.8% of this provider's total Medicare revenue), J2778 accounts for $634.8K revenue (22.8% of this provider's total Medicare revenue), and J2777 accounts for $413.3K revenue (14.8% of this provider's total Medicare revenue), indicating a high reliance on a narrow set of drug-injection revenues.

On competitive standing for injection drugs, the provider shows mixed positioning: J2778 (ranibizumab) ranks #85 of 1208 providers nationally (93th percentile), signaling above-typical national volume for that specific agent, while J0178 (aflibercept) ranks #897 of 3204 (72th percentile) and J2777 (faricimab) ranks #726 of 2039 (64th percentile), both characterized as typical or unremarkable national volumes. This pattern suggests the practice is a meaningful national participant for ranibizumab but otherwise a modest-to-typical volume provider for other anti-VEGF products.

The practice also posts unusually high utilization of diagnostic and evaluation services: 92014 is an extreme outlier (ranks #119 of 35415 providers nationally, 100th percentile) and 92134 (OCT) is an extreme outlier as well (ranks #554 of 26868, 98th percentile). Additional retinal diagnostic codes such as 92202 (ranks #63 of 2327, 97th percentile) and 92274 (ranks #3 of 70, 97th percentile) are labeled notably above typical, indicating a workflow with heavy imaging, extended ophthalmoscopy, and electrophysiologic testing alongside injection visits.

Practice scale and payer mix are effectively single-payer Medicare: Total Medicare revenue is $2.8M while Medicaid revenue is none (no Medicaid billing on file). That concentration means commercial and Medicaid exposure is not visible in these data and the provider’s revenue and operational planning appears to be driven by Medicare-covered retinal care.

Operational breadth includes both therapeutic and ancillary procedural capabilities: the practice bills 67028 (vitreous injection as a separate procedure) with $162K revenue (5.8% of Medicare revenue) and a range of diagnostic procedures such as 92235 fluorescein angiography and 76512 B-scan ultrasound, reflecting in-office capacity to perform both injections and imaging-based retinal diagnostics. This mix supports a full-service retina clinic model where treatment and imaging occur in the same setting, facilitating frequent follow-ups tied to anti-VEGF regimens.

Tenure and stability: the NPI was enumerated 2006-02-22 (~20 years ago), indicating an established provider with a long-standing Medicare presence. That longevity, combined with concentrated injection revenues and high diagnostic volumes, is consistent with a mature retina practice serving a sizable Medicare patient panel.

Data limitations and lower-volume code signals: the absence of Medicaid claims prevents assessment of care patterns for low-income populations and restricts payer-mix analysis. Several ancillary billing items (for example J3590, J3490, Q5128) appear in small dollar amounts and low national ranks, suggesting limited use of unclassified biologics or biosimilars in this practice and that most revenue is concentrated in the primary anti-VEGF codes.

Medicare: Complete Services Breakdown

The CPT/HCPCS codes generating the most Medicare revenue for this provider.

22 rows

CPT/HCPCS Code	Description	Claims	Avg Paid	Revenue
J0178	Injection, aflibercept, 1 mg	1,400	$690	$970.2K
J2778	Injection, ranibizumab, 0.1 mg	3,510	$180	$634.8K
J2777	Injection, faricimab‑svoa, 0.1 mg	14,760	$30	$413.3K
92014	An ophthalmologist sees an established patient for a comprehensive level eye examination. Generally, a patient is considered to be "established" if the same physician, or any physician in the group…	2,550	$110	$267.2K
67028	The provider injects a medication into the vitreous chamber of the eye as an isolated procedure or a separate procedure unrelated to any other procedure being performed on the eye.	1,430	$110	$162K
92134	The provider performs computerized diagnostic imaging of the retina in the posterior segment (back part) of the eye, interprets the data, and provides a report. The service may be on one or both eyes.	2,690	$40	$96.9K
J3590	Unclassified biologics	30	$2,450	$75.8K
J3490	Unclassified drugs	20	$1,850	$40.7K
Q5128	Injection, ranibizumab-eqrn (cimerli), biosimilar, 0.1 mg	150	$210	$31K
92202	The provider performs an extended ophthalmoscopy, typically with an indirect ophthalmoscope which utilizes a bright light and a hand–held indirect lens rather than the common hand–held one–piece…	1,660	$10	$23.2K

Showing 1–10 of 22

Medicare: Competitive Analysis & Benchmarks

How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 22 CPT/HCPCS codes.

View: State1 / 2

Claims Volume vs. Virginia Distribution

Reshma Katira — 4 of 22 codes billed far more than typical (above p95)

p5–p95 (all providers)p25–p75MedianThis providerOutlier

Rank Distribution — Virginia

Full comparison — all codes billed, vs. state median

22 rows

CPT/HCPCS Code	Rank	Provider Count	Median Claims	Avg Paid	Average Revenue
J0178	38	80	1,400	$690	$1.1M
J2777	27	60	13,200	$30	$517.1K
J2778	1	40	560	$180	$171.5K
J3590	10	20	40	$2,290	$126K
67028	35	90	1,000	$90	$107.1K
Q5128	7	10	190	$220	$70.7K
92014	11	870	170	$80	$32.8K
J3490	92	110	60	$280	$20.5K
92012	382	430	80	$60	$11.9K
92134	28	680	70	$30	$9.7K

Showing 1–10 of 22

Related Providers

Other providers that share a Tax Identification Number (TIN) with Reshma Katira, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
The Retina Group Of Washington, PLLC	MD	Ophthalmology Physician	$0	$19.5M
Virginia Oncology Associates	VA	Hematology & Oncology Physician	$0	$6.2M
Rohit Lakhanpal	MD	Retina Specialist (Ophthalmology) Physician	$6.1M	$0
Gordon Byrnes	VA	Retina Specialist (Ophthalmology) Physician	$4.9M	$0
Daniel Berinstein	MD	Retina Specialist (Ophthalmology) Physician	$4.3M	$0
Alexander Melamud	VA	Retina Specialist (Ophthalmology) Physician	$4.2M	$0
Michael Lai	MD	Retina Specialist (Ophthalmology) Physician	$4.2M	$0
Jordana Fein	VA	Retina Specialist (Ophthalmology) Physician	$4.2M	$0
Eric Weichel	MD	Ophthalmology Physician	$4.1M	$0
Gayatri Reilly	MD	Retina Specialist (Ophthalmology) Physician	$4.1M	$0

Nearby Providers

Other providers in the same ZIP code as Reshma Katira, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Sundeep Kasi	VA	Retina Specialist (Ophthalmology) Physician	$4.1M	$0
Franconia-springfield Surgery Center, LLC	VA	Ambulatory Surgical Clinic/Center	$1.6M	$275.4K
Simon Fishman	VA	Specialist	$624K	$0
Michael Abidin	VA	Otolaryngology/Facial Plastic Surgery Physician	$439.2K	$0
Thomas Martinelli	VA	Orthopaedic Surgery Physician	$296.7K	$0
Peter Thomas	VA	Surgery of the Hand (Surgery) Physician	$157.7K	$0
Daniel Weingold	VA	Orthopaedic Surgery Physician	$154.1K	$0
Yvette Appiah	VA	Dermatology Physician	$136.2K	$0
Iyad Saidi	VA	Otolaryngic Allergy Physician	$124.6K	$0
Angelo Pace	VA	Foot Surgery Podiatrist	$118.9K	$0

Reshma Katira — Billing Profile & Reimbursement Data

Sign up for Reshma Katira — Billing Profile & Reimbursement Data policy alerts

Reshma Katira — Billing Profile & Reimbursement Data

Sign up for Reshma Katira — Billing Profile & Reimbursement Data policy alerts

Key Findings

Medicare: Total Revenue Breakdown by CPT/HCPCS Code

Medicare: Complete Services Breakdown

Medicare: Competitive Analysis & Benchmarks

Related Providers

Nearby Providers

Frequently Asked Questions

References